Akbar Indo Makmur Stimec Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp384 (market cap 86.24B, 288.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 7.4× Akbar Indo Makmur Stimec Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 288.2K). Which is the better fit depends on your goals.
| AIMS | LABS | |
|---|---|---|
Market Cap | 86.24B | 635.95B |
Volume | 288.2K | 843K |
Lot | 2.88K | 8.43K |
Turnover | 112.41M | 137.6M |
Average Price | 390.06 | 163.22 |
Value | 112.41M | 137.6M |
Indicative Equilibrium Price | 384 | 165 |
Indicative Equilibrium Volume | 30 | 246 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Read more on AIMS →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →